Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Endo Health Solutions Inc Reaffirms FY 2013 Guidance


Thursday, 28 Feb 2013 04:06pm EST 

Endo Health Solutions Inc announced that for fiscal 2013, it expects total revenue to be between $2.80-$2.95 billion, reported (GAAP) diluted earnings per share to be between $2.22 and $2.52 and adjusted diluted earnings per share between $4.40-$4.70. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $2.92 billion and EPS of $4.55 for fiscal 2013. 

Company Quote

73.0
1.69 +2.37%
19 Dec 2014